Newsfiscal.ai
Aardvark Therapeutics Reports Exploratory Data from Terminated HERO and OLE Trials
· Published
Article summary
Aardvark Therapeutics released exploratory efficacy and safety data from its previously terminated Phase 3 HERO and open-label extension trials for ARD-101.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…